ArticleJournal for immunotherapy of cancer2024

Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer.

Zixiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.